Related Experiment Video
Updated: Sep 13, 2025

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
The Intricate Process of Calcification in Granuloma Formation and the Complications Following M. tuberculosis
Nickolas Yedgarian1, Jacqueline Agopian1, Brandon Flaig1
1College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
Abstract:
Mycobacterium tuberculosis-an acid-fast staining bacterium-is a serious global health challenge that can have both short-term and long-term complications. Although the immune response helps trap the infection, it can also cause necrosis and calcification, leading to lung tissue damage. Calcification is a known outcome of chronic granuloma evolution in TB. Multiple pathways contribute to fibrosis and calcification; some examples are IL-1β, TGF-β, and TNF-α. Current antifibrotic drugs, such as nintedanib and pirfenidone, are effective but may increase the risk of latent tuberculosis reactivation in certain patients. Experimental therapies such as artemisinin derivatives have shown promise in preclinical TB fibrosis models, while cell-based therapies like bone marrow-derived mononuclear cells are also under early investigation for dual antifibrotic and immunomodulatory effects. This literature review will explore recent studies on the pathogenesis of M. tuberculosis, the mechanisms underlying calcification in granuloma formation, and subsequent complications of the disease process.
Insights
Tuberculosis (TB) infection can lead to lung tissue damage through calcification and fibrosis. New experimental therapies show promise for treating these complications, offering hope beyond current antifibrotic drugs.
Area of Science:
- Microbiology
- Immunology
- Pathology
Background:
- Mycobacterium tuberculosis (TB) infection presents a significant global health challenge.
- Immune responses to TB can paradoxically cause lung tissue damage via necrosis and calcification.
- Calcification is a recognized consequence of chronic granuloma formation in tuberculosis.
Purpose of the Study:
- To review recent literature on the pathogenesis of M. tuberculosis.
- To explore mechanisms of calcification during granuloma formation.
- To examine subsequent disease complications and potential therapeutic strategies.
Main Methods:
- Literature review of recent studies.
- Analysis of molecular pathways involved in fibrosis and calcification (e.g., IL-1β, TGF-β, TNF-α).
- Evaluation of current and experimental therapeutic interventions.
Main Results:
- Current antifibrotic drugs (nintedanib, pirfenidone) carry risks of latent TB reactivation.
- Experimental therapies like artemisinin derivatives show preclinical promise for TB fibrosis.
- Cell-based therapies (e.g., bone marrow-derived mononuclear cells) are being investigated for combined antifibrotic and immunomodulatory effects.
Conclusions:
- Understanding TB pathogenesis and calcification mechanisms is crucial for managing lung damage.
- Novel therapeutic approaches are needed to address TB-associated fibrosis and calcification effectively.
- Further research into experimental therapies may offer safer and more effective treatments for TB complications.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
07:42A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas
Published on: June 5, 2014
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumonia III: Complications and Assessment